CREB5 has also been noted to serve as an integration site for xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer tissue from patients homozygous for a reduced activity variant of the antiviral enzyme RNase L [92]. Here, RNASEL is linked to Familial prostate cancer.